Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q3 2019 · 10-Q
Revenue—
Net Income-$3.84M-$3.84MN/M vs Q3 2018 EPS Diluted-$0.08-$0.08N/M vs Q3 2018 Operating Income-$3,920,453N/M Operating Cash Flowderived-$3,377,706N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
Free Cash Flowderived-$3,377,706— ended Sep 30, 2019 · filed Nov 14, 2019 · 45 d after period end